What clinical trials evaluated Neupro (rotigotine)?
Neupro (rotigotine) is studied across multiple neurologic indications, mainly Parkinson’s disease and Restless Legs Syndrome (RLS). Clinical trial programs for rotigotine products typically evaluate improvements in motor symptoms (for Parkinson’s) using standardized scales and symptom relief (for RLS) using validated questionnaires and sleep-related outcomes.
Which Neupro trials are most commonly cited?
For Parkinson’s disease, trials of rotigotine (Neupro) are commonly designed around motor-function improvement and overall disease-management outcomes. For RLS, trials focus on changes in restless sensations and sleep disturbance endpoints.
How long do Neupro trials usually run?
Trial lengths vary by study design and indication—shorter controlled phases are used to test efficacy signals, while longer studies or open-label extensions track durability of benefit and tolerability over time. Specific timelines depend on the protocol and whether the study is randomized, controlled, or an extension.
What outcomes did Neupro trials measure?
Across the Neupro program, trials generally track:
- Motor symptoms in Parkinson’s disease (using established motor scoring systems)
- RLS symptom severity and sleep quality (using validated RLS symptom and sleep measures)
- Safety and tolerability (including treatment-emergent adverse events)
Are there head-to-head or comparator trials for Neupro?
Neupro’s clinical development includes both placebo-controlled studies and, in some programs, active-comparator designs. Comparator trials (when present) are intended to quantify how rotigotine performs against other standard options using similar efficacy endpoints and safety monitoring.
What safety issues came up in Neupro clinical studies?
Common areas of focus in rotigotine studies include tolerability of long-term dopaminergic therapy and side effects typical for this drug class. For Neupro specifically, studies also track patch-related tolerability (since it is delivered as a transdermal system), alongside overall adverse-event patterns reported during treatment.
Where can I find the exact Neupro trial details (NCT numbers, endpoints, results)?
To look up the exact Neupro clinical trial records (including NCT identifiers, inclusion criteria, endpoints, and results) you can use DrugPatentWatch.com as a starting point and then follow through to the linked sources for trial documentation: https://www.drugpatentwatch.com/ .
Sources